The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Abstract
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D 1 and D 2 dopamine receptors have been studied in association with this condition, no causal relationship has yet been established. Taking advantage of a monkey brain bank constituted to study levodopa‐induced dyskinesia, we report changes affecting D 1 and D 2 dopamine receptors within the striatum of normal, parkinsonian, nondyskinetic levodopa‐treated parkinsonian, and dyskinetic levodopa‐treated parkinsonian animals. Whereas D 1 receptor expression itself is not related to dyskinesia, D 1 sensitivity per D 1 receptor measured by D 1 agonist‐induced [35 S]GTPγS binding is linearly related to dyskinesia. Moreover, the striata of dyskinetic animals show higher levels of cyclin‐dependent kinase 5 (Cdk5) and of the dopamine‐ and cAMP‐regulated phosphoprotein of 32kDa (DARPP‐32). Our data suggest that levodopa‐induced dyskinesia results from increased dopamine D 1 receptor–mediated transmission at the level of the direct pathway. Ann Neurol 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Self-citationGreengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 746
Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral Supersensitivity
Creese, I., Burt, D. R., & Snyder, S. H. (1977) · Science · doi:10.1126/science.877576 · Cited by 712 · cited 2×
“L-Dopa Does Not Normalize D2 Levels Previous studies have shown that DA denervation causes an increase in striatal D2 DA receptor binding sites in the postmortem tissue of untreated patients with PD and animal models.(5,6,18) Accordingly, we found that MPTP alone produced a significant increase in the levels of D2 mRN…”
BackgroundMolecular cloning and expression of the gene for a human D1 dopamine receptor
Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Bates, M. D., & Caron, M. G. (1990) · Nature · doi:10.1038/347072a0 · Cited by 674
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
Birkmayer, W., & Hornykiewicz, O. (1961) · PubMed · Cited by 541
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Self-citationPDZ Proteins Organize Synaptic Signaling Pathways
Craven, S. E., & Bredt, D. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81179-4 · Cited by 489
Cloning of the cDNA and gene for a human D2 dopamine receptor.
Grandy, D. K., Marchionni, M. A., Makam, H., Stofko, R. E., Alfano, M., Frothingham, L., Fischer, J. B., Burke-Howie, K. J., Bunzow, J. R., & Server, A. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9762 · Cited by 486
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
Self-citationEffects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
Bibb, J. A., Chen, J., Taylor, J. R., Svenningsson, P., Nishi, A., Snyder, G. L., Yan, Z., Sagawa, Z. K., Ouimet, C. C., Nairn, A. C., et al. (2001) · Nature · doi:10.1038/35066591 · Cited by 480
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
LEE, T., SEEMAN, P., RAJPUT, A., FARLEY, I. J., & HORNYKIEWICZ, O. (1978) · Nature · doi:10.1038/273059a0 · Cited by 446
Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C., & Sokoloff, P. (2003) · Nature Medicine · doi:10.1038/nm875 · Cited by 383
Self-citationA Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions
Ivar Walaas, S., Aswad, D. W., & Greengard, P. (1983) · Nature · doi:10.1038/301069a0 · Cited by 345
Molecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
Kasanetz, F., Riquelme, L. A., O'Donnell, P., & Murer, M. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113050 · Cited by 281
Boraud, T., Bezard, E., Bioulac, B., & Gross, C. E. (2001) · Brain · doi:10.1093/brain/124.3.546 · Cited by 193
Self-citationAubert, I., Ghorayeb, I., Normand, E., & Bloch, B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000228)418:1<22::aid-cne2>3.0.co;2-q · Cited by 170
Self-citationRascol, O., Nutt, J. G., Blin, O. J., Goetz, C. G., Trugman, J. M., Soubrouillard, C., Carter, J. H., Currie, L. J., Fabre, N., Thalamas, C., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.249 · Cited by 149
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum
Chergui, K., Svenningsson, P., & Greengard, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308652100 · Cited by 135
Bordet, R., Ridray, S., Schwartz, J.-C., & Sokoloff, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00089.x · Cited by 135
Seeman, P. M., Tallerico, T., & Ko, F. (2003) · Synapse · doi:10.1002/syn.10232 · Cited by 128
Graham, W. C., Sambrook, M. A., & Crossman, A. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90694-i · Cited by 85
Yoneda, Y., Tokui, K., Hanihara, T., Kitagaki, H., Tabuchi, M., & Mori, E. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<736::aid-ana7>3.0.co;2-f · Cited by 78
Optical imaging of the spatial distribution of beta-particles emerging from surfaces.
Charpak, G., Dominik, W., & Zaganidis, N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1741 · Cited by 72
Pattern of levodopa‐induced striatal changes is different in normal and MPTP‐lesioned mice
Gross, C. E., Ravenscroft, P., Doveró, S., Jaber, M., Bioulac, B. H., & Bézard, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01600.x · Cited by 50
Self-citationTheler, J., Lakhdar‐Ghazal, N., Pévet, P., Charpak, G., Dominik, W., Zaganidis, N., Dreifuss, J. J., & Dubois‐Dauphin, M. (1993) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(93)90128-e · Cited by 16
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Pathophysiology of Parkinsonism
Galvan, A., & Wichmann, T. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.017 · Cited by 549
Olanow, C. W., Obeso, J. A., & Stocchi, F. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70521-x · Cited by 547
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Self-citation
Metadata
- Authors
- Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., & Bezard, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-10-27
- Volume
- 57
- Issue
- 1
- Pages
- 17-26
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2035286056
- Cited by
- 387
- References
- 34
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.